Addus HomeCare stock heads into an October 8 investor meeting

Published on 10/08/2026 at 03:17 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Addus HomeCare stock was last at USD 113.16 on October 6, 2026, with a 0.16 percent daily gain. Q2 revenue reached USD 377.41 million and adjusted EPS USD 1.73.

ADUS, US0067391062, Illustration mit AI erstellt.

Addus HomeCare Corporation stock (ISIN US0067391062) was last at USD 113.16 on Nasdaq on October 6, 2026 at 4:00 p.m. ET, with a 0.16 percent daily gain. Management is scheduled to meet virtually with Citizens on October 8, 2026, giving investors a fresh checkpoint after the company's second-quarter results.

Citizens meeting sets the next checkpoint

According to Markets Insider on October 1, 2026, the virtual meeting with Citizens is scheduled for October 8. The event places management communication alongside the company's operating figures rather than a new earnings release.

Addus operates personal care, hospice and home health services for older adults, people with disabilities and individuals with complex medical needs. That mix makes revenue growth and cash generation important measures for investors assessing the pace of expansion.

Q2 revenue rose 8.0 percent

In its coverage of the August 3, 2026 results, MarketBeat reported second-quarter revenue of USD 377.41 million, an 8.0 percent year-over-year increase. Adjusted EPS was USD 1.73 versus a consensus estimate of USD 1.70, while the prior-year quarter produced EPS of USD 1.49.

The comparison shows a two-part picture: revenue continued to expand, while adjusted EPS exceeded consensus by USD 0.03. The next investor discussion can therefore help clarify how personal care growth, labor costs and Medicaid conditions are affecting margins and earnings quality.

Analyst target stays above the stock

MarketBeat listed a Moderate Buy consensus from 11 analysts, with targets ranging from USD 96.00 to USD 137.00 and an average target of USD 129.33. That average target lies 14.3 percent above the USD 113.16 price on October 6, 2026.

The range also signals disagreement about the stock's earnings path. Bank of America had reiterated a Neutral rating and reduced its target from USD 140.00 to USD 125.00 on September 14, 2026, according to MarketBeat.

Stock remains below its yearly high

Addus HomeCare's market capitalization was USD 2.1 billion on October 6, 2026. The stock's 52-week range was USD 87.95 to USD 124.44, placing the last price below the yearly high while keeping the October 8 meeting as the next dated corporate checkpoint.